Keywords: Boehringer Ingelheim, Actilyse, UK, NICE, Guidance, Ischemic stroke

NICE issues draft guidance on Boehringer's Actilyse

Article | 27 August 2012

Print This

UK drugs watchdog the National Institute for Health and Clinical Excellence (NICE) issued draft guidance on Friday updating its previous ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in